Altya integrates scientific discovery, translational research and commercial development within a unified innovation ecosystem — from bioactive identification and mechanism mapping to validation, proprietary platform development and international partnerships.
Our platform strategy translates scientific research into differentiated, scalable health solutions addressing emerging areas of preventive and precision healthcare.
A hallmark-driven approach targeting biological mechanisms associated with aging, cellular resilience and long-term healthspan.
A physiological support platform designed around key biological challenges associated with GLP-1-based weight management.
Exploring the biological interplay between aging, metabolism and cardiovascular resilience.
For more than two decades, Altya has advanced scientific research spanning bioactive discovery, biological mechanisms, biomarker-driven evaluation and healthy aging.
Our research approach integrates selected Hallmarks of Aging, translational science and clinical investigation to support the development of differentiated Biological Optimization platforms.
Through established collaborations with specialized Italian manufacturing partners, Altya connects scientific innovation with scalable production across multiple health-product categories.
Altya collaborates with pharmaceutical, healthcare and strategic partners seeking differentiated opportunities in Healthy Aging, Longevity and Biological Optimization.
Partnership models include platform licensing, co-development, strategic collaboration and international commercialization.
Altya Pharmaceuticals S.M.P.C.
11 Fidiou Str., 106 78 Athens, Greece
T +30 21 1008 2956
T +39 351 5195 804
E info@altya.eu